APTA.LSE Aptamer Group PLC

Healthcare Biotechnology London Exchange
0.0027 GBX
Close of Nov 3, 2026
0.2700 1.15
Market cap
GBX 9.45M
P/E
-
P/B
1.78x
ROE
-32.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is APTA.LSE undervalued?

Graham number

The Graham number of Aptamer Group PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aptamer Group PLC fundamental analysis

No fundamental analysis for Aptamer Group PLC yet.

Aptamer Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aptamer Group PLC

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therape…

Full company profile